Biodesix Inc (BDSX) stock
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$8.88−0.12 (-1.33%)
Close on Nov 17, 2026Market cap $93.69MP/E –Yield –
Biodesix revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Biodesix's revenue for the twelve months ending Jun 30, 2026 was $102.94M, up 34.5% year over year. For fiscal 2025 it was $88.50M, up 24.1% from the year before. The highest annual figure on record is $88.50M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.50M | +24.1% |
| FY2024 | Dec 31, 2024 | $71.32M | +45.3% |
| FY2023 | Dec 31, 2023 | $49.09M | +28.5% |
| FY2022 | Dec 31, 2022 | $38.21M | -29.9% |
| FY2021 | Dec 31, 2021 | $54.51M | +19.6% |
| FY2020 | Dec 31, 2020 | $45.56M | +85.6% |
| FY2019 | Dec 31, 2019 | $24.55M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $26.86M | +34.2% |
| Q1 FY2026 | Mar 31, 2026 | $25.56M | +42.3% |
| Q4 FY2025 | Dec 31, 2025 | $28.76M | +40.8% |
| Q3 FY2025 | Sep 30, 2025 | $21.77M | +19.9% |
| Q2 FY2025 | Jun 30, 2025 | $20.02M | +11.7% |
| Q1 FY2025 | Mar 31, 2025 | $17.96M | +21.2% |
| Q4 FY2024 | Dec 31, 2024 | $20.43M | +39.3% |
| Q3 FY2024 | Sep 30, 2024 | $18.15M | +34.5% |
| Q2 FY2024 | Jun 30, 2024 | $17.93M | +51.0% |
| Q1 FY2024 | Mar 31, 2024 | $14.82M | +63.6% |
| Q4 FY2023 | Dec 31, 2023 | $14.67M | +52.7% |
| Q3 FY2023 | Sep 30, 2023 | $13.49M | +21.5% |
| Q2 FY2023 | Jun 30, 2023 | $11.87M | +8.4% |
| Q1 FY2023 | Mar 31, 2023 | $9.06M | +38.3% |
| Q4 FY2022 | Dec 31, 2022 | $9.61M | +33.0% |
| Q3 FY2022 | Sep 30, 2022 | $11.11M | +70.1% |
| Q2 FY2022 | Jun 30, 2022 | $10.95M | -7.9% |
| Q1 FY2022 | Mar 31, 2022 | $6.55M | -77.3% |
| Q4 FY2021 | Dec 31, 2021 | $7.22M | -73.3% |
| Q3 FY2021 | Sep 30, 2021 | $6.53M | -29.0% |
| Q2 FY2021 | Jun 30, 2021 | $11.89M | +180.4% |
| Q1 FY2021 | Mar 31, 2021 | $28.87M | +466.4% |
| Q4 FY2020 | Dec 31, 2020 | $27.03M | +226.8% |
| Q3 FY2020 | Sep 30, 2020 | $9.19M | +133.2% |
| Q2 FY2020 | Jun 30, 2020 | $4.24M | – |
| Q1 FY2020 | Mar 31, 2020 | $5.10M | – |
| Q4 FY2019 | Dec 31, 2019 | $8.27M | – |
| Q3 FY2019 | Sep 30, 2019 | $3.94M | – |
See a number that looks wrong?